Revenue Breakdown
Composition ()
No data
Revenue Streams
Strata Skin Sciences Inc (SSKN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Dermatology Recurring Procedures, accounting for 66.8% of total sales, equivalent to $5.12M. Another important revenue stream is Dermatology Procedures Equipment. Understanding this composition is critical for investors evaluating how SSKN navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Strata Skin Sciences Inc maintains a gross margin of 60.38%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -26.80%, while the net margin is -23.41%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively SSKN converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, SSKN competes directly with industry leaders such as ITOC and BMRA. With a market capitalization of $6.30M, it holds a significant position in the sector. When comparing efficiency, SSKN's gross margin of 60.38% stands against ITOC's 79.03% and BMRA's 4.21%. Such benchmarking helps identify whether Strata Skin Sciences Inc is trading at a premium or discount relative to its financial performance.
